- $1.53bn
- $1.31bn
- $361.05m
- 80
- 31
- 41
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 120 | 117 | 220 | 297 | 361 |
Cost of Revenue | |||||
Gross Profit | 83.8 | 76 | 145 | 195 | 248 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 135 | 153 | 301 | 338 | 447 |
Operating Profit | -15.1 | -35.4 | -81.9 | -41.1 | -85.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12.6 | -34.9 | -81.6 | -36.4 | -76.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.6 | -34.9 | -75.6 | -36.6 | -74.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.6 | -34.9 | -75.6 | -36.6 | -74.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.6 | -34.9 | -75.6 | -36.6 | -74.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.273 | -0.656 | -0.901 | -0.481 | -0.413 |